DETECTION AND TREATMENT OF PROSTATE-CANCER - PERSPECTIVE OF THE UROLOGIST

被引:20
|
作者
OLSSON, CA
GOLUBOFF, ET
机构
关键词
PROSTATIC NEOPLASMS; ANTIGENS; NEOPLASM; DIAGNOSIS;
D O I
10.1016/S0022-5347(17)32364-9
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
We examine changes in the detection and treatment of prostate cancer from the perspective of the urologist. There has been an extraordinary increase in the incidence of prostate cancer (60% from 1990 to 1993). We calculated, based on data from the literature and assumptions about changes in urological practice, that 52% of newly diagnosed cases would be treated by radical prostatectomy in 1993. Extrapolating from the work of Catalona, we derived the number of office consultations, prostate biopsies and orchiectomies associated with the diagnosis and treatment of these tumors. Applying Health Care Financing Administration reimbursements to our figures, we calculated that each urologist would realize $45,370 for prostate cancer care in the Medicare population in 1993. If all patients 50 to 70 years old were screened by American Cancer Society and American Urological Association recommended algorithms, this projection would be $107,919. Despite this enormous economic impact of prostate cancer on the urologist, uncertainties remain concerning the appropriateness of screening and treatment for this disease. Only increased funding for basic research in prostate cancer will resolve these uncertainties.
引用
收藏
页码:1695 / 1699
页数:5
相关论文
共 50 条
  • [31] SERUM PROSTATE-SPECIFIC ANTIGEN COMPLEXED TO ALPHA-1-ANTICHYMOTRYPSIN AS AN INDICATOR OF PROSTATE-CANCER
    CHRISTENSSON, A
    BJORK, T
    NILSSON, O
    DAHLEN, U
    MATIKAINEN, MT
    COCKETT, ATK
    ABRAHAMSSON, PA
    LILJA, H
    JOURNAL OF UROLOGY, 1993, 150 (01) : 100 - 105
  • [32] THE VALUE OF PROSTATE-SPECIFIC ANTIGEN IN EARLY DIAGNOSIS OF PROSTATE-CANCER - THE STUDY OF MEN BORN IN 1913
    TIBBLIN, G
    WELIN, L
    BERGSTROM, R
    RONQUIST, G
    NORLEN, BJ
    ADAMI, HO
    JOURNAL OF UROLOGY, 1995, 154 (04) : 1386 - 1389
  • [33] MAGNETIC-RESONANCE-IMAGING FOR DETECTION OF PROSTATE-CANCER METASTATIC TO BONE
    TURNER, JW
    HAWES, DR
    WILLIAMS, RD
    JOURNAL OF UROLOGY, 1993, 149 (06) : 1482 - 1484
  • [34] PROSTATE-CANCER CLINICAL GUIDELINES PANEL SUMMARY REPORT ON THE MANAGEMENT OF CLINICALLY LOCALIZED PROSTATE-CANCER
    MIDDLETON, RG
    THOMPSON, IM
    AUSTENFELD, MS
    COONER, WH
    CORREA, RJ
    GIBBONS, RP
    MILLER, HC
    OESTERLING, JE
    RESNICK, MI
    SMALLEY, SR
    WASSON, JH
    JOURNAL OF UROLOGY, 1995, 154 (06) : 2144 - 2148
  • [35] RESPONSE TO FLUTAMIDE WITHDRAWAL IN ADVANCED PROSTATE-CANCER IN PROGRESSION UNDER COMBINATION THERAPY
    DUPONT, A
    GOMEZ, JL
    CUSAN, L
    KOUTSILIERIS, M
    LABRIE, F
    JOURNAL OF UROLOGY, 1993, 150 (03) : 908 - 913
  • [36] ARTIFICIAL NEURAL NETWORKS IN THE DIAGNOSIS AND PROGNOSIS OF PROSTATE-CANCER - A PILOT-STUDY
    SNOW, PB
    SMITH, DS
    CATALONA, WJ
    JOURNAL OF UROLOGY, 1994, 152 (05) : 1923 - 1926
  • [37] Magnetic resonance imaging for prostate cancer: what the urologist needs to know
    Kiechle, J. E.
    Pahwa, S.
    Gulani, V.
    Kanaan, G.
    Sedelaar, J. P.
    Ponsky, L. E.
    MINERVA UROLOGICA E NEFROLOGICA, 2015, 67 (03) : 201 - 210
  • [38] LARGE, ORGAN CONFINED, IMPALPABLE TRANSITION ZONE PROSTATE-CANCER - ASSOCIATION WITH METASTATIC LEVELS OF PROSTATE SPECIFIC ANTIGEN
    STAMEY, TA
    DIETRICK, DD
    ISSA, MM
    JOURNAL OF UROLOGY, 1993, 149 (03) : 510 - 515
  • [39] SERUM PROSTATE SPECIFIC ANTIGEN AS PRE-SCREENING TEST FOR PROSTATE-CANCER
    LABRIE, F
    DUPONT, A
    SUBURU, R
    CUSAN, L
    TREMBLAY, M
    GOMEZ, JL
    EMOND, J
    STAMEY, TA
    LANGE, PH
    JOURNAL OF UROLOGY, 1992, 147 (03) : 846 - 852
  • [40] THE PROSTATE-CANCER INTERVENTION VERSUS OBSERVATION TRIAL - A RANDOMIZED TRIAL COMPARING RADICAL PROSTATECTOMY VERSUS EXPECTANT MANAGEMENT FOR THE TREATMENT OF CLINICALLY LOCALIZED PROSTATE-CANCER
    WILT, TJ
    BRAWER, MK
    JOURNAL OF UROLOGY, 1994, 152 (05) : 1910 - 1914